Quent Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Quent Capital's LLY Position: Q1 2026 in Review
Quent Capital reduced its Eli Lilly (LLY) stake by 9.2% in Q1 2026, selling an estimated $516K and leaving 5,033 shares worth $4.63M. The position accounts for 0.33% of the portfolio, ranked #49.
Quent Capital first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.96M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Quent Capital held 5,033 shares of Eli Lilly worth $4.63M as of Q1 2026.
- Quent Capital sold 509 Eli Lilly shares in Q1 2026, an estimated $516K.
- Eli Lilly made up 0.33% of Quent Capital's portfolio in Q1 2026, its #49 holding.
- Quent Capital first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- Quent Capital's Eli Lilly position peaked at $5.96M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.